
Legal31 Jul 2026, 06:00 pm
Medplus Subsidiary's Drug License Suspended in Telangana
AI Summary
Medplus Health Services Ltd announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License for a store in Telangana. The suspension is for five days and is due to a violation under the Drugs and Cosmetics Act, 1940 and Rules, 1945. The company estimates a potential revenue loss of ₹2.34 lacs from this suspension. The details of the order will be available on the company's website and stock exchange websites.
Key Highlights
- Subsidiary's drug license suspended for five days in Telangana.
- Violation cited under Drugs and Cosmetics Act, 1940.
- Estimated revenue impact of ₹2.34 lacs.
- Order received on July 30, 2026.
Price Impact
More from MEDPLUS